Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current chemotherapy options for thymic epithelial neoplasms.

Kyriakos P Papadopoulos1, Charles R Thomas

  • 1Cancer Therapy and Research Center, Institute for Drug Development, San Antonio, TX 78229, USA.

Expert Opinion on Pharmacotherapy
|June 17, 2005
PubMed
Summary

Surgical resection is key for thymomas and thymic carcinoma. Adjuvant radiation and chemotherapy offer benefits for advanced or unresectable cases, with new targeted therapies under investigation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Sequencing Paradox of Immunotherapy and Thoracic Radiotherapy.

JAMA oncology·2026
Same author

Author Correction: SEZ6-targeting antibody-drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial.

Nature medicine·2026
Same author

Targeting of Wnt-β-Catenin Pathway in Recurrent Ameloblastoma.

The New England journal of medicine·2026
Same author

SEZ6-targeting antibody-drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial.

Nature medicine·2026
Same author

Debio 0123, a WEE1 kinase inhibitor: Phase 1 results from dose escalation in patients with advanced solid tumors.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Phase 1 LITESPARK-001 study of belzutifan in participants with advanced solid tumors: Results of the glioblastoma expansion cohort.

Neuro-oncology advances·2026

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Medical Oncology

Background:

  • Thymomas and thymic carcinoma are rare thoracic neoplasms.
  • Complete surgical resection is the primary treatment for early-stage disease.
  • Treatment strategies for advanced or unresectable thymic malignancies require further optimization.

Purpose of the Study:

  • To review current clinical data on thymoma and thymic carcinoma management.
  • To discuss the role of surgery, radiation, and chemotherapy in different disease stages.
  • To explore emerging therapeutic targets and multimodality treatment approaches.

Main Methods:

  • Review of recent clinical data and literature on thymic neoplasms.
  • Analysis of treatment outcomes based on disease stage and resectability.

Related Experiment Videos

  • Evaluation of neoadjuvant chemotherapy, surgery, and adjuvant radiation therapy protocols.

    • Main Results:

    • Complete resection is curative for Stage I thymoma.
    • The role of adjuvant radiation in Stage II thymoma is debated.
    • Chemotherapy is effective for advanced thymoma but less so for thymic carcinoma.
    • Multimodality therapy shows promise for unresectable thymic malignancies.

    Conclusions:

    • Surgical resection remains the cornerstone of thymic neoplasm treatment.
    • Adjuvant radiation and chemotherapy have specific roles in managing advanced or incompletely resected disease.
    • Targeted therapies and novel treatment combinations are areas for future research.